Easing PPE demands | Vaccines and kids | Antiviral therapeutics

Easing PPE demands

National Personal Protective Technology Laboratory in Pittsburgh–which has been developing a new kind of respirator that would ease demand for N95s masks during the pandemic–has received a $14 million grant from the U.S. Department of Health.

Double lung transplant on COVID patient

In December, surgeons at OSU’s Wexner Medical Center Comprehensive Transplant Center successfully performed a lifesaving double lung transplant on a patient who recovered from COVID-19. Since then, they have performed three more lung transplants.

Vaccines and kids

Cincinnati Children’s is now testing Pfizer’s COVID-19 vaccine in children between the ages of five and 11, with a focus currently on getting the dosage right.

Sanitizing vending machines

An Iowa company has developed new sanitation tech: UV vending machines. The machines use UV rays but include safeguards such as a shielding that directs radiation to target surfaces and a shut off mechanism for when a consumer approaches the machine.

COVID-19 innovation

Minneapolis-based Bio-Techne Corporation today announced that its R&D Systems and Novus brands have been named winners of the CiteAb COVID-19 Innovation Award for its products that helped shape the life sciences sectors understanding of, or resilience to, COVID-19.

Antiviral therapeutics

Phytoption, a startup in the Purdue Research Park, is looking for partners to help advance the development of antiviral therapeutics it says could fight against COVID-19 and other viral diseases.